Notably, Remodelin efficiently attenuated NSCLC proliferation, invasion, and migration by inhibiting NAT10 through the epithelial‐mesenchymal transition (EMT) pathway. This evidence concerns the gene NAT10 and non-small cell lung carcinoma.